SCOLR Pharma, Inc. (SCLR) [Rocket]

In millions, except per share items	Sep-30-11	Jun-30-11	Mar-31-11	Dec-31-10	Sep-30-10	Jun-30-10	Mar-31-10	Dec-31-09
	10-Q	10-Q	10-Q	10-K	10-Q	10-Q	10-Q	10-K
Revenues
Licensing fees						0.1
Royalty income	0.0	0.1			0.2	0.1
Research and development	0.0	0.1			0.2	0.1
Total revenues	0.0	0.1	0.3	0.3	0.3	0.2	0.9	0.9
Total revenues growth	-94.2%	-40.8%	-62.7%	-62.9%	-58.8%	-72.7%	7.6%	-2.3%
Operating expenses
Marketing and selling	0.1	0.1			0.2	0.1
Research and development	0.0	0.2			0.5	0.3
General and administrative	1.1	1.2			1.2	0.6
Total operating expenses	1.2	1.5			1.9	0.9
Loss from operations	-1.1	-1.4			-1.6	-0.7
Operating margin	-5650.0%	-1057.6%			-449.6%	-309.9%

Other income (expense)
Interest income	0.2	0.0
Interest expense	-0.2	0.0

Unrealized gain (loss) on fair value of warrant
Other	-0.2	-0.1			-0.1	0.0
Total other (expense)	-0.2	-0.1			0.1	0.2
Net loss	-1.3	-1.5			-1.4	-0.5

Net loss per share, basic and diluted	($0.03)	($0.03)			($0.03)	($0.01)

Shares used in computing basic and diluted net loss per share	24.9	24.9			24.9	12.4